Kaufman Howard 4
4 · Replimune Group, Inc. · Filed Dec 19, 2019
Insider Transaction Report
Form 4
Kaufman Howard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-11-26$3.30/sh+58,067$191,621→ 58,067 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-11-26−58,067→ 91,135 totalExercise: $3.30Exp: 2027-09-01→ Common Stock (58,067 underlying)
Footnotes (1)
- [F1]On September 1, 2017 the Reporting Person was granted an option to purchase 149,202 shares of the Issuer's common stock, 25% of which vested on September 1, 2018 and the remainder of which vested or will vest in 36 equal monthly installments thereafter.